The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Immunopathogenesis and therapy of cutaneous T cell lymphoma
Open accessAbstract
Cutaneous T cell lymphomas (CTCLs) are a heterogenous group of lymphoproliferative disorders caused by clonally derived, skin-invasive T cells. Mycosis fungoides (MF) and Sezary syndrome (SS) are the most common types of CTCLs and are characterized by malignant CD4(+)/CLA(+)/CCR4(+) T cells that also lack the usual T cell surface markers CD7 and/or CD26. As MF/SS advances, the clonal dominance of the malignant cells results in the expression of predominantly Th2 cytokines, progressive immune dysregulation in patients, and further tumor cell growth. This review summarizes recent insights into the pathogenesis and immunobiology of MF/SS and how these have shaped current therapeutic approaches, in particular the growing emphasis on enhancement of host antitumor immune responses as the key to successful therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WHO-EORTC classification for cutaneous lymphomas
Willemze, R. (2005) · Blood · doi:10.1182/blood-2004-09-3502 · Cited by 3,803
Kawai, T., Sato, S., Ishii, K. J., Coban, C., Hemmi, H., Yamamoto, M., Terai, K., Matsuda, M., Inoue, J.-I., Uematsu, S., et al. (2004) · Nature Immunology · doi:10.1038/ni1118 · Cited by 1,033
Immune surveillance in the skin: mechanisms and clinical consequences
Kupper, T. S., & Fuhlbrigge, R. C. (2004) · Nature Reviews Immunology · doi:10.1038/nri1310 · Cited by 805
Duvic, M., Hymes, K., Heald, P., Breneman, D., Martin, A. G., Myskowski, P., Crowley, C., Yocum, R. C., & for Members of the Bexarotene Worldwide Study Group (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.9.2456 · Cited by 706
Kim, Y. H., Liu, H. L., Mraz-Gernhard, S., Varghese, A., & Hoppe, R. T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.7.857 · Cited by 653
Kelly, W. K., Richon, V. M., O’Connor, O. A., Curley, T., MacGregor‐Cortelli, B., Tong, W. P., Klang, M. G., Schwartz, L. B., Richardson, S., Rosa, E., et al. (2003) · PubMed · Cited by 624
Self-citationOlsen, E., Duvic, M., Frankel, A., Kim, Y., Martin, A., Vonderheid, E., Jegasothy, B., Wood, G., Gordon, M., Heald, P., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.2.376 · Cited by 609
Effect of interleukin‐10 on dendritic cell maturation and function
de Smedt, T., van Mechelen, M., De Becker, G., Urbain, J., Leo, O., & Moser, M. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270526 · Cited by 565
Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., Olsen, E., Pittelkow, M., Russell-Jones, R., Takigawa, M., et al. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.118538 · Cited by 493
Piekarz, R. L., Robey, R., Sandor, V., Bakke, S., Wilson, W. H., Dahmoush, L., Kingma, D. M., Turner, M. L., Altemus, R., & Bates, S. E. (2001) · Blood · doi:10.1182/blood.v98.9.2865 · Cited by 445
The epidemiology of non-Hodgkin's lymphoma
Fisher, S. G., & Fisher, R. I. (2004) · Oncogene · doi:10.1038/sj.onc.1207843 · Cited by 425
IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells
Strengell, M., Matikainen, S., Sirén, J., Lehtonen, A., Foster, D., Julkunen, I., & Sareneva, T. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5464 · Cited by 394
Lundin, J., Hagberg, H., Repp, R., Cavallin-Ståhl, E., Fredén, S., Juliusson, G., Rosenblad, E., Tjønnfjord, G., Wiklund, T., & Österborg, A. (2003) · Blood · doi:10.1182/blood-2002-09-2802 · Cited by 390
The Pathogenesis of Mycosis Fungoides
Girardi, M., Heald, P. W., & Wilson, L. D. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032810 · Cited by 389
(2003) · PubMed · Cited by 355
Wood, G. S., Tung, R. M., Heaffner, A. C., Crooks, C. F., Liao, S., Orozco, R., Veelken, H., Kadin, M. E., Koh, H., Heald, P., et al. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12389114 · Cited by 349
IL-15 Promotes the Survival of Naive and Memory Phenotype CD8+ T Cells
Berard, M., Brandt, K., Paus, S. B., & Tough, D. F. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5018 · Cited by 343
Niwa, R., Shoji-Hosaka, E., Sakurada, M., Shinkawa, T., Uchida, K., Nakamura, K., Matsushima, K., Ueda, R., Hanai, N., & Shitara, K. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2068 · Cited by 325
Molecular sequelae of histone deacetylase inhibition in human malignant B cells
Mitsiades, N., Mitsiades, C. S., Richardson, P. G., McMullan, C., Poulaki, V., Fanourakis, G., Schlossman, R., Chauhan, D., Munshi, N. C., Hideshima, T., et al. (2003) · Blood · doi:10.1182/blood-2002-11-3514 · Cited by 294
Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M., & Kikuchi, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04999.x · Cited by 292
Rook, A. H., Wood, G. S., Yoo, E. K., Elenitsas, R., Kao, D. M. F., Sherman, M. L., Witmer, W. K., Rockwell, K. A., Shane, R. B., Lessin, S. R., et al. (1999) · Blood · doi:10.1182/blood.v94.3.902.415k23_902_908 · Cited by 277
Self-citationKim, S., Elkon, K. B., & Ma, X. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.009 · Cited by 277
Mycosis fungoides and Sezary syndrome [see comments]
Diamandidou, E., Cohen, P., & Kurzrock, R. (1996) · Blood · doi:10.1182/blood.v88.7.2385.bloodjournal8872385 · Cited by 273
CpG motifs: the active ingredient in bacterial extracts?
Krieg, A. M. (2003) · Nature Medicine · doi:10.1038/nm0703-831 · Cited by 271
Yoo, E. K., Rook, A. H., Elenitsas, R., Gasparro, F. P., & Vowels, B. R. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12329711 · Cited by 270
Self-citationIncreased CCR4 Expression in Cutaneous T Cell Lymphoma
Ferenczi, K., Fuhlbrigge, R. C., Kupper, T. S., Pinkus, J. L., & Pinkus, G. S. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19610.x · Cited by 265
Th2 Cytokine mRNA Expression in Skin in Cutaneous T-Cell Lymphoma
Vowels, B. R., Lessin, S. R., Cassin, M., Jaworsky, C., Benoit, B., Wolfe, J. T., & Rook, A. H. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12398454 · Cited by 263
Self-citationClinicopathological spectrum of mycosis fungoides
Kazakov, D., Burg, G., & Kempf, W. (2004) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2004.00937.x · Cited by 262
Lundin, J., Osterborg, A., Brittinger, G., Crowther, D., Dombret, H., Engert, A., Epenetos, A., Gisselbrecht, C., Huhn, D., Jaeger, U., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3257 · Cited by 255
Vowels, B. R., Cassin, M., Vonderheid, E. C., & Rook, A. H. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12611877 · Cited by 248
Self-citationCutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells
Berger, C. L., Tigelaar, R., Cohen, J., Mariwalla, K., Trinh, J., Wang, N., & Edelson, R. L. (2005) · Blood · doi:10.1182/blood-2004-06-2181 · Cited by 245
Zhang, C., Hazarika, P., Ni, X., Weidner, D. A., & Duvic, M. A. (2002) · PubMed · Cited by 223
Zhang, Q., Nowak, I., Vonderheid, E. C., Rook, A. H., Kadin, M. E., Nowell, P. C., Shaw, L. M., & Wasik, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9148 · Cited by 221
Self-citationInfections Complicating Mycosis Fungoides and Sézary Syndrome
Axelrod, P. I. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480100060031 · Cited by 219
Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality.
Weinstock, M. A., & Gardstein, B. (1999) · American Journal of Public Health · doi:10.2105/ajph.89.8.1240 · Cited by 216
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells
Bernengo, M. G., Novelli, M., Quaglino, P., Lisa, F., De Matteis, A., Savoia, P., Cappello, N., & Fierro, M. T. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04014.x · Cited by 201
Kari, L., Loboda, A., Nebozhyn, M., Rook, A. H., Vonderheid, E. C., Nichols, C., Virok, D., Chang, C., Horng, W.-H., Johnston, J., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021726 · Cited by 199
Self-citationPiekarz, R. L., Robey, R. W., Zhan, Z., Kayastha, G., Sayah, A., Abdeldaim, A. H., Torrico, S., & Bates, S. E. (2004) · Blood · doi:10.1182/blood-2003-09-3068 · Cited by 186
Imiquimod and resiquimod as novel immunomodulators
Dockrell, D. H. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.751 · Cited by 185
Hoppe, R. T., Medeiros, L. J., Warnke, R. A., & Wood, G. S. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90067-5 · Cited by 182
Cutaneous T Cell Lymphoma: The Helping Hand of Dendritic Cells
EDELSON, R. L. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03705.x · Cited by 174
Profound loss of T-cell receptor repertoire complexity in cutaneous T-cell lymphoma
Yawalkar, N., Ferenczi, K., Jones, D. A., Yamanaka, K., Suh, K.-Y., Sadat, S., & Kupper, T. S. (2003) · Blood · doi:10.1182/blood-2003-04-1044 · Cited by 172
Mao, X., Lillington, D., Scarisbrick, J. J., Mitchell, T., Czepulkowski, B., Russell-Jones, R., Young, B., & Whittaker, S. J. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04966.x · Cited by 163
Sommer, V. H., Clemmensen, O. J., Nielsen, O., Wasik, M., Lovato, P., Brender, C., Eriksen, K. W., Woetmann, A., Kaestel, C. G., Nissen, M. H., et al. (2004) · Leukemia · doi:10.1038/sj.leu.2403385 · Cited by 162
Ishida, T., Iida, S., Akatsuka, Y., Ishii, T., Miyazaki, M., Komatsu, H., Inagaki, H., Okada, N., Fujita, T., Shitara, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0983 · Cited by 161
Kakinuma, T., Sugaya, M., Nakamura, K., Kaneko, F., Wakugawa, M., Matsushima, K., & Tamaki, K. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.132 · Cited by 151
Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K.-P., Burg, G., Dummer, R., & Nestle, F. O. (2003) · Blood · doi:10.1182/blood-2002-08-2455 · Cited by 145
Interferon in the Treatment of Cutaneous T-cell Lymphoma
Olsen, E. A., & Bunn, P. A. (1995) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30060-1 · Cited by 144
Asadullah, K., Döcke, W., Haeuβler, A., Sterry, W., & Volk, H. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12330869 · Cited by 130
Suchin, K. R., Cucchiara, A. J., Gottleib, S. L., Wolfe, J. T., DeNardo, B. J., Macey, W. H., Bromley, P. G., Vittorio, C. C., & Rook, A. H. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.8.1054 · Cited by 123
Self-citationImmune modulation and apoptosis induction: Two sides of the antitumoral activity of imiquimod
Schön, M. P., & Schön, M. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000025805.55340.c3 · Cited by 122
Immune Surveillance and Effector Functions of CCR10+ Skin Homing T Cells
Hudak, S. A., Hagen, M., Liu, Y., Catron, D., Oldham, E. R., McEvoy, L. M., & Bowman, E. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.3.1189 · Cited by 121
Kallinich, T., Muche, J. M., Qin, S., Sterry, W., Audring, H., & Kroczek, R. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12555.x · Cited by 121
Knobler, R., Trautinger, F., Radaszkiewicz, T., Kokoschka, E., & Micksche, M. (1991) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(91)70036-2 · Cited by 113
Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity
Lonsdorf, A. S., Kuekrek, H., Stern, B. V., Boehm, B. O., Lehmann, P., & Tary‐Lehmann, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.3941 · Cited by 112
Son, Y. I., Dallal, R. M., Mailliard, R. B., Egawa, S., Jonak, Z., & Lotze, M. T. (2001) · PubMed · Cited by 109
Wood, G. S., Hong, S. R., Sasaki, D. T., Abel, E., Hoppe, R. T., Warnke, R. A., & Morhenn, V. B. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70080-2 · Cited by 106
Prognostic Value of Blood Eosinophilia in Primary Cutaneous T-Cell Lymphomas
Tancrède‐Bohin, E., Ionescu, M., Salmonière, P. D. L., Dupuy, A., Rivet, J., Rybojad, M., Dubertret, L., Bachelez, H., Lebbé, C., & Morel, P. (2004) · Archives of Dermatology · doi:10.1001/archderm.140.9.1057 · Cited by 105
Dereure, O., Levi, E., Kadin, M. E., & Vonderheid, E. C. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01794.x · Cited by 104
Wysocka, M., Benoit, B. M., Newton, S. B., Azzoni, L., Montaner, L. J., & Rook, A. H. (2004) · Blood · doi:10.1182/blood-2004-03-1190 · Cited by 97
Self-citationSuchin, K. R. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.9.1137 · Cited by 96
The T-Cell Chemokine Receptor CXCR3 Is Expressed Highly in Low-Grade Mycosis Fungoides
Lü, D., Duvic, M. A., Medeiros, L. J., Luthra, R., Dorfman, D. M., & Jones, D. (2001) · American Journal of Clinical Pathology · doi:10.1309/3n7p-j84l-jq9k-g89r · Cited by 93
Delfau‐Larue, M., Dalac, S., Lepage, É., Petrella, T., Wechsler, J., Farcet, J., & Bagot, M. (1998) · Blood · doi:10.1182/blood.v92.9.3376 · Cited by 92
McGregor, J. M., Crook, T., Fraser-Andrews, E. A., Rozycka, M., Crossland, S., Brooks, L. A., & Whittaker, S. J. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00507.x · Cited by 89
Retinoids: therapeutic applications and mechanisms of action in cutaneous T-cell lymphoma
Zhang, C., & Duvic, M. A. (2003) · Dermatologic Therapy · doi:10.1111/j.1396-0296.2003.01644.x · Cited by 89
Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: A case series
Singh, F., & Lebwohl, M. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.05.010 · Cited by 85
Yoo, E. K., Cassin, M., Lessin, S. R., & Rook, A. H. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.116345 · Cited by 81
Self-citationWysocka, M., Zaki, M. H., French, L. E., Chehimi, J., Shapiro, M., Everetts, S. E., McGinnis, K. S., Montaner, L. J., & Rook, A. H. (2002) · Blood · doi:10.1182/blood-2002-01-0231 · Cited by 77
Self-citationTritel, M., Stoddard, A. M., Flynn, B. J., Darrah, P. A., Wu, C. Y., Wille, U., Shah, J. A., Huang, Y., Xu, L., Betts, M. R., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2538 · Cited by 77
The Sézary syndrome: hematologic criteria
Vonderheid, E. C., & Bernengo, M. G. (2003) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(03)00120-5 · Cited by 76
Wu, J. J., Huang, D., & Tyring, S. K. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.07.002 · Cited by 76
Biological Effects of Bexarotene in Cutaneous T-Cell Lymphoma
Budgin, J. B., Richardson, S. K., Newton, S. B., Wysocka, M., Zaki, M. H., BENOIT, B., & Rook, A. H. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.3.315 · Cited by 75
Self-citationMiller, G., Pillarisetty, V. G., Shah, A. B., Lahrs, S., Xing, Z., & DeMatteo, R. P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.2875 · Cited by 69
McGinnis, K. S., Junkins‐Hopkins, J. M., Crawford, G., Shapiro, M., Rook, A. H., & Vittorio, C. C. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2003.10.669 · Cited by 61
Self-citationHurwitz, D., Pincus, L. B., & Kupper, T. S. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.10.1347 · Cited by 59
Scarisbrick, J. J., Mitchell, T. J., Calonje, E. J., Orchard, G. E., Russell‐Jones, R., & Whittaker, S. J. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12496.x · Cited by 57
Psoriasiform mycosis fungoides with fatal outcome after treatment with cyclosporine
Zackheim, H. S., Koo, J. Y. M., LeBoit, P. E., McCalmont, T. H., Bowman, P. H., Kashani–Sabet, M., Jones, C. D., & Zehnder, J. L. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120571 · Cited by 55
Psoralen Plus Long-Wave UV-A (PUVA) and Bexarotene Therapy
McGinnis, K. S., Shapiro, M., Vittorio, C. C., Rook, A. H., & Junkins‐Hopkins, J. M. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.6.771 · Cited by 52
Self-citationp16INK4a Is Selectively Silenced in the Tumoral Progression of Mycosis Fungoides
Navas, I. C., Algara, P., Mateo, M. S., Martínez, P., García, C., Rodriguez, J. L., Vanaclocha, F., Barrientos, N., Iglesias, L., Sánchez, L., et al. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780405 · Cited by 51
Fox, F. E., Kubin, M. Z., Cassin, M., Niu, Z., Trinchieri, G., Cooper, K. D., & Rook, A. H. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099314117 · Cited by 50
Self-citationTransimmunization and the evolution of extracorporeal photochemotherapy
Girardi, M., Schechner, J. S., Glusac, E. J., Berger, C. L., & Edelson, R. L. (2002) · Transfusion and Apheresis Science · doi:10.1016/s1473-0502(02)00011-3 · Cited by 45
The Potential Therapeutic Role of Interleukin‐12 in Cutaneous T‐Cell Lymphomaa
Rook, A. H., RUBIN, M., Fox, F. E., Niu, Z., Cassin, M., Vowels, B. R., Gottleib, S. L., Vonderheid, E. C., Lessin, S. R., & TRINCHIERF, G. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb52680.x · Cited by 38
Self-citationSchwab, C., Willers, J., Niederer, E. M., Ludwig, E., Kündig, T. M., Grob, P. J., Burg, G., & Dummer, R. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03726.x · Cited by 38
Retroviruses and Cutaneous T-Cell Lymphoma
Lessin, S. R., Vowels, B. R., & Rook, A. H. (1994) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30172-4 · Cited by 28
Self-citationMolecular Genetics of Cutaneous Lymphomas
Whittaker, S. J. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03709.x · Cited by 28
Improved detection of clonality in cutaneous T‐cell lymphomas using laser capture microdissection
Yazdi, A. S., Medeiros, L. J., Puchta, U., Thaller, E., Flaig, M. J., & Sander, C. A. (2003) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2003.00099.x · Cited by 26
Definition of TCR Epitopes for CTL-Mediated Attack of Cutaneous T Cell Lymphoma
Winter, D., Fiebiger, E., Meraner, P., Auer, H., Brna, C., Strohal, R., Trautinger, F., Knobler, R., Fischer, G., Stingl, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.5.2714 · Cited by 23
Camacho, L. H., Ribas, A., Glaspy, J. A., Lopez‐Berestein, G., Reuben, J. M., Parker, C., Seja, E., Comı́n-Anduix, B., Bulanhagui, C. A., & Gómez-Navarro, J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.2505 · Cited by 19
Shapiro, M., Rook, A. H., Lehrer, M. S., Junkins‐Hopkins, J. M., French, L. E., & Vittorio, C. C. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.124816 · Cited by 18
Self-citationAmerican Society of Hematology meeting
Baynes, R. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92900-9 · Cited by 12
Bergstrom, R. T., Silverman, D. A., Chambers, K., & Kim, J. A. (2004) · Otolaryngology · doi:10.1016/j.otohns.2003.09.007 · Cited by 9
Cited by
Piekarz, R. L., Frye, R., Turner, M., Wright, J. J., Allen, S. L., Kirschbaum, M. H., Zain, J., Prince, H. M., Leonard, J. P., Geskin, L. J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.6150 · Cited by 740
Campbell, J. J., Clark, R. A., Watanabe, R., & Kupper, T. S. (2010) · Blood · doi:10.1182/blood-2009-11-251926 · Cited by 519
Genomic landscape of cutaneous T cell lymphoma
Choi, J., Goh, G., Walradt, T., Hong, B. S., Bunick, C. G., Chen, K., Bjornson, R. D., Maman, Y., Wang, T., Tordoff, J., et al. (2015) · Nature Genetics · doi:10.1038/ng.3356 · Cited by 428
CCR4 and its ligands: from bench to bedside
Yoshie, O., & Matsushima, K. (2015) · International Immunology · doi:10.1093/intimm/dxu079 · Cited by 427
EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome
Trautinger, F., Knobler, R., Willemze, R., Peris, K., Stadler, R., Laroche, L., D’Incan, M., Ranki, A., Pimpinelli, N., Ortiz-Romero, P., et al. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.01.025 · Cited by 416
Metadata
- Authors
- Kim, E. J., Hess, S., Richardson, S. K., Newton, S., Showe, L. C., Benoit, B. M., Ubriani, R., Vittorio, C. C., Junkins-Hopkins, J. M., Wysocka, M., & Rook, A. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-04-01
- Volume
- 115
- Issue
- 4
- Pages
- 798-812
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162093324
- Cited by
- 413
- References
- 91
- FWCI
- 31.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.